TERMIUM Plus^®

Record 1,  Textual support,  English

Record number: 1, Textual support number: 1 CONT

A "chiral switch" occurs in the pharmaceutical market when a drug made up of 2 enantiomer forms is replaced with a purified single-enantiomer version, often in the context of a patent expiration.  2, record 1, English, - chiral%20switch

Record 1,  Textual support,  French

Record number: 1, Textual support number: 1 DEF

Remplacement, dans un médicament, d'un principe actif initialement racémique par son eutomère.  2, record 1, French, - glissement%20chiral

Record number: 1, Textual support number: 1 OBS

glissement chiral : désignation et définition publiées au Journal officiel de la République française le 28 janvier 2020.  3, record 1, French, - glissement%20chiral

Record 1,  Textual support,  Spanish

Record 2,  Textual support,  French

Record 2,  Textual support,  Spanish

Record 3,  Textual support,  English

Record number: 3, Textual support number: 1 CONT

Every drug receives three distinct names : the chemical name, the generic(or nonproprietary) name, and the brand(or proprietary or trademark) name.... The generic name is commonly used by health care professionals and is usually created when a new drug is ready to be marketed. Although the manufacturer or sponsor of the drug has exclusive right of manufacture during the 17 years of the drug's patent, it never owns the generic name.... In the United States, the generic name must first be approved by the U. S. Adopted Name(USAN) Council and then by the World Health Organization(WHO).... After approving the generic name, the Council submits the name to WHO, which has final approval.... After being approved by WHO, the drug is assigned an international nonproprietary name.  6, record 3, English, - nonproprietary%20name

Record number: 3, Textual support number: 2 CONT

Once a chemical substance has become frequently cited in the literature, it will be identified with simplified nomenclature popularly known as a "generic" name. This nonproprietary name is preferred in database indexing over all other types of drug nomenclature. MEDLINE [registered trademark] cites the United States Adopted Name (USAN) as a standard, when available. USANs are officially approved designations adopted by the FDA for uniformity in labeling and regulatory references. EMBASE®, on the other hand, prefers International Nonproprietary Names (INNs), promulgated by the World Health Organization, as drug descriptors. Caution: the USAN and INN "generic" name for the same drug may differ. Other official nomenclature standards include: British Approved Name (BAN), Nordiska Farmakopenamden (NFN), and Dénomination Commune Francaise (DCF).  7, record 3, English, - nonproprietary%20name

Record 3,  Textual support,  French

Record number: 3, Textual support number: 1 DEF

Nom auquel ne s'attache aucun droit de propriété, tels les noms officiellement agréés, les noms de pharmacopée ou les dénominations libres.  3, record 3, French, - d%C3%A9nomination%20commune

Record 3,  Textual support,  Spanish

Record 4,  Textual support,  English

Record number: 4, Textual support number: 1 DEF

A drug or remedy protected by a trademark, available without prescription.  1, record 4, English, - patent%20medicine

Record number: 4, Textual support number: 1 CONT

Parliament should amend the Patent Act and/or the Patented Medicines Regulations to provide for a mechanism for interim or conditional pricing of a new patented medicine upon its introduction to the Canadian market ...  5, record 4, English, - patent%20medicine

Record 4,  Textual support,  French

Record number: 4, Textual support number: 1 CONT

D'après la Loi de l'engagement de Jean Chrétien envers l'Afrique, un médicament breveté qui est fabriqué à des fins d'exportation vers un pays en développement, avec l'accord du commissaire aux brevets, doit être différencié de sa version vendue au Canada.  2, record 4, French, - m%C3%A9dicament%20brevet%C3%A9

Record 4,  Textual support,  Spanish

Record 5,  Textual support,  English

Record number: 5, Textual support number: 1 CONT

There are also composition of matter patent for medicine itself, process patent for the manufacturing method of medicine and pharmaceutical patent for the preparation of medicine.  4, record 5, English, - medicine%20patent

Record number: 5, Textual support number: 2 CONT

Medicines themselves can now be patented. Accordingly, there are three types of claims that can be made in a medicine patent: a claim for the medicine itself, known as a product claim ...  5, record 5, English, - medicine%20patent

Record number: 5, Textual support number: 3 CONT

As an incentive, pharmaceutical companies that conduct these studies might receive an extension of their medication patent for the product being tested ...  6, record 5, English, - medicine%20patent

Record 5,  Textual support,  French

Record number: 5, Textual support number: 1 CONT

La durée de vie du brevet de médicament avait été normalement fixée par le droit commun à vingt ans, mais compte-tenu d'une part du coût [...] de la durée de mise au point et des innombrables essais thérapeutiques en vue d'obtenir l'autorisation de mise sur le marché (A.M.M.) [...]  2, record 5, French, - brevet%20de%20m%C3%A9dicament

Record 5,  Textual support,  Spanish

Record 6,  Textual support,  English

Record number: 6, Textual support number: 1 CONT

A non-patented medicine is a drug that is not protected by a patent, including generic drugs and some brand name drugs.  4, record 6, English, - unlicensed

Record number: 6, Textual support number: 2 CONT

Where any person passes any unpatented product off as patented product or passes any unpatented process off as patented process, such person shall be ordered by the administrative authority for patent affairs to stop the passing off, correct it publicly, and pay a fine.  5, record 6, English, - unlicensed

Record 6,  Textual support,  French

Record number: 6, Textual support number: 1 CONT

Un médicament non breveté est un médicament qui ne bénéficie pas de la protection d'un brevet. Les médicaments génériques et certains médicaments de marque s'inscrivent dans cette catégorie de médicaments.  2, record 6, French, - non%20brevet%C3%A9

Record 6,  Textual support,  Spanish

Record 7,  Textual support,  English

Record number: 7, Textual support number: 1 CONT

Every drug receives three distinct names : the chemical name, the generic(or nonproprietary) name, and the brand(or proprietary or trademark) name.... The generic name is commonly used by health care professionals and is usually created when a new drug is ready to be marketed. Although the manufacturer or sponsor of the drug has exclusive right of manufacture during the 17 years of the drug's patent, it never owns the generic name.... In the United States, the generic name must first be approved by the U. S. Adopted Name(USAN) Council and then by the World Health Organization(WHO).... After approving the generic name, the Council submits the name to WHO, which has final approval.... After being approved by WHO, the drug is assigned an international nonproprietary name.  5, record 7, English, - international%20nonproprietary%20name

Record 7,  Textual support,  French

Record number: 7, Textual support number: 1 DEF

dénomination commune internationale : Nom proposé par l'OMS [Organisation mondiale de la santé] pour désigner la substance qui sert de principe actif dans une préparation pharmaceutique.  3, record 7, French, - d%C3%A9nomination%20commune%20internationale

Record 7,  Textual support,  Spanish

Record 8,  Textual support,  English

Record number: 8, Textual support number: 1 CONT

We have received one issued U. S. patent covering our shotgun antisense technology for identifying essential genes and two additional U. S. patents covering certain essential gene drug targets and research tools in fungi. In addition, we have filed another 25 patent applications including claims to over 4, 000 essential gene drug targets, four gene discovery methods, and four drug screening technologies.  1, record 8, English, - gene%20drug

Record 8,  Textual support,  French

Record number: 8, Textual support number: 1 CONT

On distingue actuellement trois approches majeures : le gène-médicament, la protéine-médicament et le ligand-médicament. Le gène-médicament permet d'envisager de «réparer» un gène défectueux ou d'adjoindre dans les cellules un gène codant pour une protéine potentiellement thérapeutique : c'est l'approche par thérapie génique.  1, record 8, French, - g%C3%A8ne%2Dm%C3%A9dicament

Record 8,  Textual support,  Spanish

Record 9,  Textual support,  French

Record 9,  Textual support,  Spanish